mTOR blockade by rapamycin could profoundly ameliorate splenomegaly by limiting lymphocytes proliferation, angiogenesis, fibrogenesis and inflammation as well as decreasing portal pressure in portal hypertensive rats. The gene discussed is MTOR; the disease is Splenomegaly.